Showing results (901-910 of 11,113) with videos related to

Sort By:
Pageof 1,112
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics-The Pilot Case Series StudyMarek Krzystanek, Anna Warchala, Beata Trędzbor, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Pharmacology and Adverse Events of Emergency-Use Authorized Medication in Moderate to Severe COVID-19Jen-Yu Hsu, Yan-Chiao Mao, Po-Yu Liu, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Urothelial Calcium-Sensing Receptor Modulates Micturition Function via Mediating Detrusor Activity and Ameliorates Bladder Hyperactivity in RatsWei-Yi Wu, Shih-Pin Lee, Bing-Juin Chiang, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Discovery of a Novel Tetrapeptide against Influenza A Virus: Rational Design, Synthesis, Bioactivity Evaluation and Computational StudiesMaria Carmina Scala, Mariangela Agamennone, Agostina Pietrantoni, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Retinoids in Fungal Infections: From Bench to BedsideTerenzio Cosio, Roberta Gaziano, Guendalina Zuccari, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Rediscovering Psilocybin as an Antidepressive Treatment StrategyRene Zeiss, Maximilian Gahr, Heiko Graf
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Implications of Antigen Selection on T Cell-Based ImmunotherapyFaye A Camp, Jill E Slansky
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic ApproachPaola Orlandi, Anna Solini, Marta Banchi, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Discovery of a Novel Class of Norovirus Inhibitors with High Barrier of ResistanceJana Van Dycke, Michela Puxeddu, Giuseppe La Regina, et al.
Pageof 1,112